The radiology department at the hospital I work at is asking about the safety of this drug, Eovist, generic name gadoxetate, for breastfeeding mothers during MRI. I did not find information on it on the forums or in the most recent edition of your book. Any information would be appreciated. Thank you!
Announcement
Collapse
No announcement yet.
Welcome to our forum! Before posting your questions, please read the following terms:
- 1. Forum questions will be responded to by InfantRisk staff as schedules permit during normal business hours.
- 2. This forum is not intended for emergencies or urgent care. For any immediate medical concerns, please seek appropriate medical attention.
- 3. Any statements made by team members should be discussed with your medical care team. Your healthcare providers know you (and your baby) best, and should have a better understanding of your unique situation.
- 4. We are a small team dedicated to helping you as best as we can. However, for the quickest response, we recommend calling the InfantRisk Center at +1(806) 352-2519.
By posting to the forums, you acknowledge and agree to these terms.
The InfantRisk team
Eovist / gadoxetate
Collapse
X
-
LCBrenda:
Eovist is a gadolinium-containing radiocontrast agent. We have about 5 or so of these radio contrast agents. The one that has been studied, is virtually excluded from the milk compartment. Levels in milk are low, and it is not orally absorbed.
Similarly, this drug has a half-life of about 1 hour, thus all of it would be gone in 5 hours. With this family of drugs, the American College of Radiology generally suggests that you do not need to discontinue breastfeeding at all. I generally suggest waiting a few hours (3-4) pump and discard the milk once, and then go on to breastfeeding.
Tom Hale PhD.
Comment